Carlos N. Velez

Carlos N. Velez is the Chief Executive Officer at Connexin Therapeutics Ltd., where Carlos N. focuses on developing connexin inhibitors for retinal neuroprotection. Carlos N. is also the Managing Partner at Lacerta Bio dealing with pharma/biotech business development and consulting. Additionally, Carlos works as an Instructor at EBD Academy and has held positions such as Vice President of Business Development at CMTx BioTech, Director of Business Development at Panion Animal Health, and Partner at Ventac Partners in the life science industry. Carlos has a Ph.D. in Pharmacy from the University of North Carolina at Chapel Hill, a BS in Pharmacy from Albany College of Pharmacy and Health Sciences, and an MBA in Management and Finance from Rochester Institute of Technology.